LAMOTRIGINE

Antiepileptic medicine

Dosage Forms

Tablet

100 mg

Uses

  • Focal seizures
  • Tonic-clonic seizures
  • Atypical absence seizures in children
  • Seizures associated with Lennox Gastaut syndrome
  • Bipolar disorder

Dose and Duration

Monotherapy of seizures

Adult and child over 12 years: initially 25 mg once daily for 14 days, increased to 50 mg once daily for 14 days, and then increased every 7–14 days by no more than 100 mg.

Usual maintenance dose 100–200 mg daily in 1–2 divided doses (up to 500 mg daily)

Monotherapy of typical absence seizures

Child 2–12 year: initially 0.3 mg/kg daily in 1–2 divided doses for 14 days then 0.6 mg/kg daily in 1–2 divided doses for further 14 days, thereafter increased by max 0.6 mg/kg every 7–14 days.

Usual maintenance 1–10 mg/kg daily in 1–2 divided doses (max 15 mg/kg)

Adjunctive therapy of seizures with valproate

Adult and child over 12 years: initially 25 mg on alternate days for 14 days then 25 mg once daily for more 14 days, thereafter increased by max 50 mg every 7–14 days.

Usual maintenance, 100–200 mg daily in 1–2 divided doses

Child 2–12 years: initially 0.15 mg/kg once daily for 14 days (give 2 mg on alternate days if body weight is below 13 kg) then 0.3 mg/kg once daily for further 14 days, thereafter increased by max 0.3 mg/kg every 7–14 days.

Usual maintenance 1–5 mg/kg daily in 1–2 divided doses (max 200 mg daily in 2 divided doses)

Adjunctive therapy of seizures (with enzyme inducing drugs) without valproate

Adult and child over 12 years: initially 50 mg once daily for 14 days then 50 mg every 12 hours for more 14 days, thereafter increased by max 100 mg every 7–14 days.

Usual maintenance 100–200 mg every 12 hours (up to 700 mg daily has been required)

Child 2–12 years: initially 0.3 mg/kg every 12 hours for 14 days then 0.6 mg/kg every 12 hours for more 14 days, thereafter increased by max 1.2 mg/kg every 7–14 days.

Usual maintenance dose 2.5–7.5 mg/kg every 12 hours (max 200 mg every 12 hours)

Adjunctive therapy of seizures (without enzyme inducing drugs) without valproate

Adult and child over 12 years: same as in monotherapy for seizures above

Child 2–12 years: same as above in monotherapy of typical absence seizures. Max 200 mg daily

Monotherapy or adjunctive therapy of bipolar disorder (without enzyme inducing drugs) without valproate

Adult over 18 years: initially 25 mg once daily for 14 days, then 50 mg daily in 1–2 divided doses for further 14 days, then 100 mg daily in 1–2 divided doses for further 7 days.

Usual maintenance 200 mg daily in 1–2 divided doses (max 400 mg daily)

Adjunctive therapy of bipolar disorder with valproate

Adult over 18 years: initially 25 mg on alternate days for 14 days, then 25 mg once daily for further 14 days, then 50 mg daily in 1–2 divided doses for further 7 days.

Usual maintenance 100 mg daily in 1–2 divided doses (max 200 mg daily)

Adjunctive therapy of bipolar disorder (with enzyme inducing drugs) without valproate

Adult over 18 years: initially 50 mg once daily for 14 days, then 50 mg every 12 hours for further 14 days, then 100 mg every 12 hours for further 7 days, then 150 mg every 12 hours for further 7 days.

Usual maintenance 200 mg every 12 hours

Contraindications

  • Hypersensitivity to lamotrigine

Side Effects

  • Nausea, vomiting, diarrhoea, dry mouth
  • Aggression, agitation, headache, drowsiness, insomnia
  • Tremor, ataxia, back pain, arthralgia
  • Nystagmus, diplopia, blurred vision
  • Skin rash, Stevens-Johnson syndrome

Interactions

  • Rifampicin (plasma concentration of lamotrigine reduced)
  • Tricyclic antidepressants, SSRIs, antipsychotics, mefloquine (anticonvulsant effect of lamotrigine antagonised)
  • Valproate (increased concentration and toxicity of lamotrigine)
  • Oestrogens (reduced concentration of lamotrigine)
  • Orlistat (increased risk of convulsions)

Patient Instructions

  • Watch out for signs of bone marrow depression such as anaemia, bruising and infection

Pregnancy

  • Can be used

Breast-feeding

  • Can be used

⚠️ Caution

  • Closely monitor and withdraw lamotrigine immediately if signs of hypersensitivity such as rash and fever occur
  • Avoid abrupt withdrawal; taper off over 2 weeks or longer unless a serious skin reaction occurs
  • Use caution when switching between oral formulations
  • Use half dose in moderate hepatic impairment and quarter dose in severe impairment
  • Reduce dose in severe renal failure
  • In pregnancy, use the lowest possible dose. Consider co-administration of folate
  • Monitor infant for side effects and avoid abrupt withdrawal since withdrawal effects may develop in a breast-fed infant
  • Dose titration is required if restarting lamotrigine after an interval of more than 5 days